Adverse placental effects of valproic acid: Studies in perfused human placentas
Epilepsia Apr 23, 2018
Rubinchik-Stern M, et al. - This study characterized the effects of short exposure to valproic acid (VPA) on the expression of carriers for compounds essential for fetal development in human placentas ex vivo, under controlled conditions. VPA was found to considerably alter the mRNA levels of major carriers for folic acid, glucose, choline, thyroid hormones, and serotonin and reduced placental folate concentrations by 25%-35%. The placenta served as a novel target of VPA, which exhibited the potential involvement of the placenta in VPA's adverse fetal outcomes.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries